Mohammed Bouhajib - Concepedia

Author

Mohammed Bouhajib

Pharmaceutical Product Development (United States)

Also Known As

M Bouhajib, M. Bouhajib, Mohammed Bouhajib, Mohammed. Bouhajib

Publications

613

Citations

H-Index

Concepts

All Affiliations

Pharmaceutical Product Development (United States)Celerion (United States)University of Colorado Colorado Springs PRA Health Sciences Worldwide Clinical Trials (United States)

About

Mohammed Bouhajib is an author at Pharmaceutical Product Development (United States) specializing in medicine, pharmacology, and clinical chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	465
2	Engineering	11	11	251
3	Education	1	1	19
4	Health Sciences	1	1	88
5	Natural Sciences	1	1	18

Mohammed Bouhajib

Publications

511

Citations

H-Index

Page 1

	Year	Citations
Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa Abdelwahab Omri, Christian Beaulac, Mohammed Bouhajib, Antimicrobial Agents and Chemotherapy Intratracheal AdministrationAntimicrobial SusceptibilityHealth SciencesAntibioticsMedicine	1994	88
The pharmacokinetics and cardiovascular effects of high-dose articaine with 1:100,000 and 1:200,000 epinephrine Elliot V. Hersh, Helen Giannakopoulos, Lawrence M. Levin, The Journal of the American Dental Association Pharmacological StudyCardiovascular DiseaseMedicineHigh-dose ArticaineClinical Pharmacology	2006	81
Recommendations on The Interpretation of The New European Medicines Agency Guideline on Bioanalytical Method Validation By Global Cro Council For Bioanalysis (Gcc) Mark Boterman, Mira Doig, Massimo Breda, Bioanalysis Global Cro CouncilEngineeringVerification And ValidationBioanalysisAnalytical Chemistry	2012	44
Recommendations on Incurred Sample Stability (ISS) by GCC Steve Lowes, Richard LeLacheur, Ronald E. Shoup, Bioanalysis EngineeringSample TreatmentRobustness TestingSoftware AnalysisPerformance Portability	2014	34
Recommendations on Bioanalytical Method Stability Implications of Co-Administered And Co-Formulated Drugs By Global Cro Council For Bioanalysis (Gcc) Steve Lowes, Mark Boterman, Mira Doig, Bioanalysis Pharmaceutical ScienceGlobal Cro CouncilCo-formulated DrugsBioanalysisStability Data	2012	32
8th GCC: Consolidated Feedback to US FDA on The 2013 Draft FDA Guidance on Bioanalytical Method Validation Joseph Bower, Douglas M. Fast, Fabio Garofolo, Bioanalysis EngineeringVerification And ValidationConsolidated FeedbackTranslational MedicineProcess Analytical Technology	2014	31
Conference Report: 6Th Gcc Focus on Lba: Critical Reagents, Positive Controls And Reference Standards; Specificity For Endogenous Compounds; Biomarkers; Biosimilars Robert I. Nicholson, Steve Lowes, Maria Cruz Caturla, Bioanalysis Global Cro CouncilEngineeringReagentPre-clinical PharmacologyConference Report	2012	27
Conference Report: 4Th Global Cro Council For Bioanalysis: Coadministered Drugs Stability, Ema/Us Fda Guidelines, 483S And Carryover Steve Lowes, Jim Jersey, Ronald E. Shoup, Bioanalysis Global Cro CouncilEngineeringPharmacotherapyTranslational MedicineBiologic Agent	2012	23
7th GCC Insights: Incurred Samples Use; Fit-For-Purpose Validation, Solution Stability, Electronic Laboratory Notebook and Hyperlipidemic Matrix Testing Mario L. Rocci, Steve Lowes, Ronald E. Shoup, Bioanalysis EngineeringMeasurementEducationVerification And ValidationCalibration	2014	19
The Essential Oil and Glycosidically Bound Volatile Compounds of<i>Taxus canadensis</i>Marsh France-Ida Jean, François-X. Garneau, Guy J. Collin, Journal of Essential Oil Research BiologyFood ChemistryAgricultural ChemistryConifer Taxus CanadensisVolatile Compounds	1993	18

Page 1